Literature DB >> 8757878

Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae.

M J Gill1, D P McQuillen, J P van Putten, L M Wetzler, J Bramley, H Crooke, N J Parsons, J A Cole, H Smith.   

Abstract

Previous studies indicate that sialylation of lipopolysaccharide (LPS) by host CMP-N-acetylneuraminic acid (CMP-NANA) catalyzed by bacterial sialyltransferase rendered gonococci resistant to killing by phagocytes, to entry into epithelial cell lines, to killing by immune serum and complement, and to absorption of complement component C3. These results have been confirmed by comparing a sialyltransferase-deficient mutant (strain JB1) with its parent (strain F62) in appropriate tests. In contrast to F62, JB1 was very susceptible to killing by human polymorphonuclear phagocytes in opsonophagocytosis tests and incubation with CMP-NANA did not decrease the level of killing. The inherent resistance of F62 in these tests was probably due to LPS sialylation by CMP-NANA and lactate present in the phagocytes. A JB1 variant expressing the invasion-associated Opa protein was as able to enter Chang human conjunctiva epithelial cells as an Opa-positive variant of F62, suggesting that the sialyltransferase is not required for Opa-mediated entry. After incubation with CMP-NANA, the number of F62 variant gonococci entering cells but not that of JB1 variant gonococci was drastically reduced. Both JB1 and F62 were killed by incubation with rabbit antibody to gonococcal major outer membrane protein, protein I, and human complement, but only F62 was rendered resistant to the killing by incubation with CMP-NANA. Finally, both JB1 and F62 absorbed similar amounts of complement component C3 and the binding was decreased by incubation with CMP-NANA only for the wild type, F62.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757878      PMCID: PMC174232          DOI: 10.1128/iai.64.8.3374-3378.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.

Authors:  J J Kim; D Zhou; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.

Authors:  L M Wetzler; K Barry; M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 3.  Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity.

Authors:  H Smith; N J Parsons; J A Cole
Journal:  Microb Pathog       Date:  1995-12       Impact factor: 3.738

4.  Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistance.

Authors:  N J Parsons; G J Boons; P R Ashton; P D Redfern; P Quirk; Y Gao; C Constantinidou; J Patel; J Bramley; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1996-02       Impact factor: 3.738

5.  A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts.

Authors:  J Bramley; R Demarco de Hormaeche; C Constantinidou; X Nassif; N Parsons; P Jones; H Smith; J Cole
Journal:  Microb Pathog       Date:  1995-03       Impact factor: 3.738

6.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.

Authors:  R F Rest; J V Frangipane
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Glucose metabolism in Neisseria gonorrhoeae.

Authors:  S A Morse; S Stein; J Hines
Journal:  J Bacteriol       Date:  1974-11       Impact factor: 3.490

8.  Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated.

Authors:  C Elkins; N H Carbonetti; V A Varela; D Stirewalt; D G Klapper; P F Sparling
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

9.  In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.

Authors:  R E Mandrell; A J Lesse; J V Sugai; M Shero; J M Griffiss; J A Cole; N J Parsons; H Smith; S A Morse; M A Apicella
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane.

Authors:  L M Wetzler; E C Gotschlich; M S Blake; J M Koomey
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Lactate stimulation of gonococcal metabolism in media containing glucose: mechanism, impact on pathogenicity, and wider implications for other pathogens.

Authors:  H Smith; E A Yates; J A Cole; N J Parsons
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.

Authors:  Hong Wu; Ann E Jerse
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.

Authors:  U Vogel; A Weinberger; R Frank; A Müller; J Köhl; J P Atkinson; M Frosch
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

Review 5.  Questions about the behaviour of bacterial pathogens in vivo.

Authors:  H Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

6.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

7.  Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement.

Authors:  Jennifer M Slaney; Alexandra Gallagher; Joseph Aduse-Opoku; Keith Pell; Michael A Curtis
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

8.  Natural proteoglycan receptor analogs determine the dynamics of Opa adhesin-mediated gonococcal infection of Chang epithelial cells.

Authors:  J P van Putten; S F Hayes; T D Duensing
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

9.  Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.

Authors:  Amanda L Lewis; Lloyd S Robinson; Kavita Agarwal; Warren G Lewis
Journal:  Glycobiology       Date:  2016-09-09       Impact factor: 4.313

10.  A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes.

Authors:  Hong Wu; Angel A Soler-García; Ann E Jerse
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.